Pharmaceutical companies that submit Marketing Authorization Application (MAA) in Switzerland are required to have a Pharmaceutical Establishment Licence (PEL).

We offer to submit MAA for pharmaceutical companies without Swiss subsidiary in the name of Target BioScience AG.  We can transfer Marketing Authorization to your, in the meantime established Swiss subsidiary at any time of your choice. 

• Prepare and submission of MAA under Target BioScience AG
• Assistance in establishment of your Swiss subsidiary
• Follow-up and finalization of the marketing authorization
• Transfer the marketing authorization licence to your Swiss subsidiary or any other pharmaceutical company in Switzerland you might choose.

We understand the unique regulatory requirements for Orphan Drugs and offer unique solutions to your challenges. With this process, we help you to shorten time to the market substantially. Please contact us to receive more information.